Price movement over the last 24 hours
Align Technology, Inc. vs Bank of America Corp — how do they compare? Align Technology, Inc. trades at $176.01 (market cap $13.27B), while Bank of America Corp trades at $58.66 (market cap $424.80B). The key difference: Bank of America Corp is far larger — about 32× Align Technology, Inc.'s market cap, and Bank of America Corp pays a 1.87% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | BAC | |
|---|---|---|
Market Cap | $13.27B | $424.80B |
Sector | Health | Financials |
52-Week High | $207.19 | $59.90 |
52-Week Low | $124.88 | $44.92 |
Enterprise Value | $12.32B | — |
Volume | — | 55,637,172 |
Dividend Yield | — | 1.87% |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
Bank of America (BAC) trades at $59.9, up 1.99% today, near the analyst consensus price target of $63.79. The stock shows strong technical momentum with a bullish moving average signal, though RSI levels indicate potential overbought conditions. Fundamentally, BAC delivered three consecutive quarterly earnings beats, with Q1 2026 EPS of $1.11 exceeding expectations. Revenue grew to $113.1 billion in 2025, and the net income margin improved to 26.97%. Recent news highlights strategic partnerships and a focus on talent acquisition.
BAC presents a favorable outlook with robust earnings growth, a dominant deposit franchise, and positive analyst sentiment (64.8% buy ratings). Key opportunities include potential capital returns post-stress tests and AI-driven efficiency gains. Risks involve interest rate sensitivity, macroeconomic pressures on lending, and regulatory changes. The stock's current valuation (P/E 14.86) appears reasonable relative to historical performance, supporting a constructive view for long-term investors.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.
Read more on BAC →